Peter Kowey, MD, has disclosed the following financial relationships:

Consultant/Advisory Board: AstraZeneca, Cardiome Pharma Corp., GlaxoSmithKline, Procter & Gamble, sanofi-aventis, Solvay Pharmaceuticals, Wyeth

Dr Kowey has indicated that he will include reference to off-label/investigational uses of drugs or devices in his presentation, including discussion of the investigational use of antiarrhythmic drugs for AF, which is not approved for this use by the FDA.